Natixis’s Teladoc Health TDOC Stock Holding History

Natixis’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$6.46M	–	1226
2023 Q4	$6.46M	Buy	+300,000	New	+$5.53M	0.05%	273

Other funds holding TDOC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Natixis's TDOC Position: Q1 2026 in Review

Natixis sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 94,400 shares — an estimated $661K sold.

Natixis first reported a position in TDOC in Q3 2017 and held it in 25 quarters. The position peaked at $56.2M in Q3 2021. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Natixis reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
Natixis sold 94,400 Teladoc Health shares in Q1 2026, an estimated $661K.
Natixis first reported a position in Teladoc Health in Q3 2017 and held it in 25 quarters.
Natixis's Teladoc Health position peaked at $56.2M in Q3 2021.
322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.